BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 14636492)

  • 1. [Prevalence of chronic obstructive pulmonary disease and risk factors in smokers and ex-smokers].
    Jaén Díaz JI; de Castro Mesa C; Gontán García-Salamanca MJ; López de Castro F
    Arch Bronconeumol; 2003 Dec; 39(12):554-8. PubMed ID: 14636492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender and chronic obstructive pulmonary disease in high-risk smokers.
    de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
    Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of chronic obstructive pulmonary disease among smokers attending primary healthcare clinics in Saudi Arabia.
    Al Ghobain M; Al-Hajjaj MS; Wali SO
    Ann Saudi Med; 2011; 31(2):129-33. PubMed ID: 21403413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study.
    Al Ghobain M; Alhamad EH; Alorainy HS; Al Kassimi F; Lababidi H; Al-Hajjaj MS
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1252-7. PubMed ID: 26459542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
    Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
    Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
    Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J;
    Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care].
    Clotet J; Gómez-Arbonés X; Ciria C; Albalad JM
    Arch Bronconeumol; 2004 Apr; 40(4):155-9. PubMed ID: 15030729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence and characteristics of chronic obstructive pulmonary disease in non-smokers].
    Montserrat-Capdevila J; Godoy P; Marsal JR; Ortega M; Barbé F; Castañ MT; Seminario MA; Pujol J; Alsedà M
    Aten Primaria; 2019 Dec; 51(10):602-609. PubMed ID: 30454958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study.
    van Gemert F; Kirenga B; Chavannes N; Kamya M; Luzige S; Musinguzi P; Turyagaruka J; Jones R; Tsiligianni I; Williams S; de Jong C; van der Molen T
    Lancet Glob Health; 2015 Jan; 3(1):e44-51. PubMed ID: 25539969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
    Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
    Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease.
    Chun EM; Kim SW; Lim SY
    Int J Chron Obstruct Pulmon Dis; 2015; 10():955-60. PubMed ID: 26028968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
    Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
    Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of asthma-COPD overlap syndrome among primary care asthmatics with a smoking history: a cross-sectional study.
    Kiljander T; Helin T; Venho K; Jaakkola A; Lehtimäki L
    NPJ Prim Care Respir Med; 2015 Jul; 25():15047. PubMed ID: 26182124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstructive airway disease in 46-65-year-old people in Busselton, Western Australia, 1966-2015.
    Musk AB; Hunter M; Hui J; Knuiman MW; Divitini M; Beilby JP; James A
    Med J Aust; 2018 Mar; 208(5):209-213. PubMed ID: 29540142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, Risk Factors and Diagnostic Accuracy of COPD Among Smokers in Primary Care.
    Llordés M; Jaén A; Almagro P; Heredia JL; Morera J; Soriano JB; Miravitlles M
    COPD; 2015 Aug; 12(4):404-12. PubMed ID: 25474184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in chronic obstructive pulmonary disease phenotypes between non-smokers and smokers.
    Ji W; Lim MN; Bak SH; Hong SH; Han SS; Lee SJ; Kim WJ; Hong Y
    Clin Respir J; 2018 Feb; 12(2):666-673. PubMed ID: 27805311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoke, Biomass Exposure, and COPD Risk in the Primary Care Setting: The PUMA Study.
    Montes de Oca M; Zabert G; Moreno D; Laucho-Contreras ME; Lopez Varela MV; Surmont F
    Respir Care; 2017 Aug; 62(8):1058-1066. PubMed ID: 28559464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPD and its association with smoking in the Mainland China: a cross-sectional analysis of 0.5 million men and women from ten diverse areas.
    Kurmi OP; Li L; Wang J; Millwood IY; Chen J; Collins R; Guo Y; Bian Z; Li J; Chen B; Xie K; Jia W; Gao Y; Peto R; Chen Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():655-65. PubMed ID: 25848242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
    Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
    Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.